Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ras homolog family member Q (RHOQ, also known as TC10) is a small (~21 kDa) GTPase belonging to the Rho family, part of the Ras superfamily of signaling proteins. RHOQ functions as a molecular switch, cycling between inactive GDP-bound and active GTP-bound states to regulate signal transduction pathways. It plays a critical role in actin cytoskeleton organization, cell shape, adhesion, motility, and epithelial cell polarization. RHOQ also regulates membrane trafficking events, such as the exocytosis of glucose transporter GLUT4 and possibly CFTR. It is associated with inherited disorders such as epilepsy and dyschromatosis symmetrica hereditaria. While it is an important signaling and structural regulator in physiology, no direct clinical therapeutics currently target RHOQ.
Not directly exploited pharmacologically, but inhibition or activation of RHOQ would be expected to alter actin cytoskeleton dynamics, cell polarization, and vesicle trafficking. In analogy to other Rho GTPases, modulators may act by inhibiting the GTPase or GEF/GAP interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras homolog family member Q (RHOQ).